In the realm of clinical research, medical devices constitute a diverse and critical category. At Genelife Clinical Research, we bring our extensive experience and unwavering commitment to excellence to the forefront in the conduct of medical device and drug-device combination clinical trials.
Medical device clinical trials present unique complexities compared to drug trials. One of the key challenges is the absence of a perfect control group, making study design pivotal in overcoming these constraints. Furthermore, the concept of “absolute safety and efficacy” is elusive in medical device trials, as experimentation on healthy human subjects rarely provides definitive answers. Instead, outcomes tend to be study-specific, limiting their direct applicability to the real world.
Innovative Study Designs for Medical Devices
To address these challenges, Genelife Clinical Research employs innovative study designs tailored to the nuances of medical device trials. Two crucial postulates guide our approach:
-
Variation of the Hypothesis: In many medical device clinical trials, we structure the study hypothesis to specifically test particular outcomes. This tailored approach ensures the relevance and effectiveness of the study.
-
Inclusion of Subsets: Exclusion of subsets of the population can lead to results that do not align with real-world scenarios. Therefore, we proactively include predetermined subsets in our study designs, enhancing the study’s applicability and statistical power.
Genelife Clinical Research possesses the expertise to assist clients in navigating the complex regulatory landscape of medical devices. We are well-versed in the submission of Investigational Device Exemptions (IDE) and 510(k) premarket notifications.
Moreover, we assist our clients in integrating various medical device regulatory requirements into their quality management systems, including ISO 13485, 21CFR820, Canadian Medical Devices Conformity Assessment (CMDCAS), and the Medical Device Directive (MDD). This comprehensive approach ensures that our clients’ quality management systems are not only compliant but also scalable to meet the global requirements for medical device market approval and distribution.
Moreover, we assist our clients in integrating various medical device regulatory requirements into their quality management systems, including ISO 13485, 21CFR820, Canadian Medical Devices Conformity Assessment (CMDCAS), and the Medical Device Directive (MDD). This comprehensive approach ensures that our clients’ quality management systems are not only compliant but also scalable to meet the global requirements for medical device market approval and distribution.
At Genelife Clinical Research, we recognize the intricacies of medical device trials and have positioned ourselves as a trusted partner for those seeking to navigate this complex terrain. Our commitment to innovation, ethical conduct, and excellence ensures that we provide high-quality outcomes in the ever-evolving field of medical device clinical research.